A new company, Rodin Therapeutics, that will apply epigenetics to the search for new therapies for neurological disorders is being launched by Atlas Venture LP of Cambridge, Massachusetts, US and Proteros biostructures GmbH of Germany. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
